Concepedia

Sanjal H. Desai

SH

5

Publications

88

Citations

5

H-Index

2020

Active since

Affiliations

Huntsman Cancer Institute(Current)

University of Utah

Mayo Clinic

University of Minnesota

WinnMed

Sanjal H. Desai is an author at Huntsman Cancer Institute specializing in humoral immunity, medicine, and autoimmunity.

ORCID

Top concepts

Publications per year

2020–2023

5

Publications

5

Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma

Sanjal H. Desai, Michael A. Spinner, Kevin A. David et al. · American Journal of Hematology · 2023 · 28 citations · Full text

Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors

Christopher Pleyer, Clare Sun, Sanjal H. Desai et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 25 citations · Full text

, , +16

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes

Charlotte B Wagner, Kenneth M. Boucher, Adrienne Nedved et al. · Haematologica · 2023 · 12 citations · Full text

PD-1 Blockade before Autologous Stem Cell Transplantation Improves Outcomes in Relapsed/Refractory Classic Hodgkin Lymphoma: Results from a Multicenter Cohort

Sanjal H. Desai, Reid W. Merryman, Harsh Shah et al. · Blood · 2023 · 12 citations

Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study

Sanjal H. Desai, Betsy LaPlant, William R. Macon et al. · Blood Cancer Journal · 2021 · 11 citations · Full text

Rows per page

1–5 of 5